Rxo (RXO) Current Assets (2021 - 2026)

Rxo (RXO) has 6 years of Current Assets data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 6.37% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 6.37% YoY), and the FY2025 full-year result was $1.3 billion, down 1.64% from the prior year.
• Current Assets for Q1 2026 stood at $1.3 billion, up from $1.3 billion in the prior quarter.
• Across five years, Current Assets topped out at $1.3 billion in Q4 2024 and bottomed at $770.0 million in Q1 2024.
• The 5-year median for Current Assets is $1.2 billion (2025), against an average of $1.1 billion.
• Peak annual rise in Current Assets reached 68.22% in 2024, while the deepest fall reached 25.17% in 2024.
• A 5-year view of Current Assets shows it stood at $1.0 billion in 2022, then retreated by 22.64% to $796.0 million in 2023, then jumped by 68.22% to $1.3 billion in 2024, then retreated by 1.64% to $1.3 billion in 2025, then climbed by 1.37% to $1.3 billion in 2026.
• The last three Current Assets figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.

Peer Comparison